Does RIBOCICLIB Cause Urinary retention? 89 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Urinary retention have been filed in association with RIBOCICLIB (KISQALI). This represents 0.3% of all adverse event reports for RIBOCICLIB.
89
Reports of Urinary retention with RIBOCICLIB
0.3%
of all RIBOCICLIB reports
21
Deaths
63
Hospitalizations
How Dangerous Is Urinary retention From RIBOCICLIB?
Of the 89 reports, 21 (23.6%) resulted in death, 63 (70.8%) required hospitalization, and 23 (25.8%) were considered life-threatening.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 89 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which RIBOCICLIB Alternatives Have Lower Urinary retention Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN